CO PR ee K 022.32 |
So Mk kK oN ob Ww
OCT 18 2002
Attachment IV
510(k) Summary

Submitter: Sciton, Inc.

Address: 845 Commercial Street, Palo Alto, CA 94303

Phone: (650) 493-9155

Fax: (650) 493-9146

Contact Person: Jay M. Patel, Director of Regulatory Affairs

Date Prepared: July 15, 2002

Device Trade Name: Profile 1320 Laser System

Common Name: Nd:YAG Laser System

Classification Name: Laser Surgical Instrument, 21 CFR 878.4810.

Legally Marketed CoolTouch Nd:YAG Laser System (K002347)

Predicate Device:

Description of Profile 1320 Laser System is an Nd:YAG laser producing

Profile 1320 Laser System: emission at a wavelength of 1320 nm. It consists of a laser
console, internal computer, control panel and display, an
optical delivery system comprised of an articulated arm
and a handpiece or scanner with cooling capability, and a
footswitch.

Intended Use: The Profile 1320 Laser System is indicated for use in
general surgery and dermatology for the incision, excision,
ablation, vaporization, coagulation, with hemostasis of soft
tissue.

Rationale for Substantial The Profile 1320 Laser System shares the same

Equivalence: indications for use, similar design features (including

: wavelength, laser medium, power supply, cooling and
control system), functional features (including power
output, repetition rate, energy, spot size and fluence), and
is therefore substantially equivalent to the above legally
marketed predicate device.

pe es
ie Z DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
AN € —_—— | | "
era . : : Food and Drug Administration
. . . , : 9200 Corporate Boulevard /
: : Rockville MD 20850
- OCT 1 8 2002
Sciton, Inc. . : , Jay M. Patel a : an
_ Director, Regulatory Affairs -.
. 845 Commercial Street
Palo Alto, California 94303
Re: K022381 ,
Trade/Device Name: Profile 1320 Laser System
Regulation Number: 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery
and in dermatology
Regulatory Class: Class II
Product Code: GEX
Dated: July 15, 2002
Received: July 22, 2002
Dear Mr. Patel:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

: . Page 2— Mr. Jay M. Patel : :
This letter will allow you to begin marketing your device as described in your Section 510(k)
: premarket notification. The FDA finding of substantial equivalence of your device to a legally
. marketed predicate device results in a classification for your device and thus, permits your device to - proceed to the market. a Ce
: If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of /
: Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the :
regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the Division
of Small Manufacturers, International and Consumer Assistance at its toll-free number (800)
638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
TU 4 C . Fave
er Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

7 , Attachment Ill ,
Oe Statement of Indications for Use :
. 510(k) Number (if known): ____K022381 . : oe
oe _ Device Name: Profile 1 320 Laser System _ :
Indications for Use:
The Profile 1320 Laser System is indicated for use in general surgery and
dermatology for the incision, excision, ablation, vaporization, coagulation
and hemostasis of soft tissue.
(PLEASE DO NOT WRITE BELOW THiS LINE — CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use V4 OR = Over-The-Counter Use
(Per 21CFR801)
< , 7 .
main Curve
(Division Sign-Off)
Division of General, Restorative
and Neuralogical Devices
2D
510(k) Number KO%8 35]

